Skip to main content

01.10.2006 | Review | Ausgabe 5/2006

Breast Cancer Research 5/2006

High-throughput genomic technology in research and clinical management of breast cancer. Exploiting the potential of gene expression profiling: is it ready for the clinic?

Breast Cancer Research > Ausgabe 5/2006
Andrew H Sims, Kai Ren Ong, Robert B Clarke, Anthony Howell
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​bcr1605) contains supplementary material, which is available to authorized users.
Andrew H Sims, Kai Ren Ong contributed equally to this work.

Competing interests

The authors declare that they have no competing interests.


Gene expression profiling is a relatively new technology for the study of breast cancers, but within the past few years there has been a rapid rise in interest in its potential to improve the clinical management of breast cancer. This technology has contributed to our knowledge of the molecular pathology of breast tumours and shows promise as a tool to predict response to therapy and outcome, such as risk of metastasis. Microarray technology is continually developing and it is becoming apparent that, despite the various platforms available, robust conclusions can still be drawn that apply across the different array types. Gene expression profiling is beginning to appear in the breast cancer clinic but it is not yet fully evaluated. This review explores the questions that must be addressed before this technology can become an everyday clinical tool.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Über diesen Artikel

Weitere Artikel der Ausgabe 5/2006

Breast Cancer Research 5/2006 Zur Ausgabe